Wealth Enhancement Advisory Services’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-63,739
Closed -$13.3K 3161
2024
Q3
$13.3K Hold
63,739
﹤0.01% 2706
2024
Q2
$14.7K Hold
63,739
﹤0.01% 2504
2024
Q1
$54.8K Buy
63,739
+44,126
+225% +$30.2K ﹤0.01% 2338
2023
Q4
$7.65K Hold
19,613
﹤0.01% 2295
2023
Q3
$31.4K Buy
+19,613
New +$54.2K ﹤0.01% 2179

Other funds holding RNLX

Wealth Enhancement Advisory Services's RNLX Position: Q4 2024 in Review

Wealth Enhancement Advisory Services sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 63,739 shares — an estimated $13.3K sold.

Wealth Enhancement Advisory Services first reported a position in RNLX in Q3 2023 and held it in 5 quarters. The position peaked at $54.8K in Q1 2024. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.

  • Wealth Enhancement Advisory Services reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 63,739 Renalytix plc American Depositary Shares shares in Q4 2024, an estimated $13.3K.
  • Wealth Enhancement Advisory Services first reported a position in Renalytix plc American Depositary Shares in Q3 2023 and held it in 5 quarters.
  • Wealth Enhancement Advisory Services's Renalytix plc American Depositary Shares position peaked at $54.8K in Q1 2024.
  • 3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.

Based on Wealth Enhancement Advisory Services's 13F filing for Q4 2024, filed 10 Jan 2025.